Ustekinumab successfully treated a patient with severe psoriasis vulgaris with primary failure to infliximab and secondary failure to adalimumab

Journal Title: Nasza Dermatologia Online - Year 2015, Vol 6, Issue 2

Abstract

Biologic drugs have been recently used to treat psoriasis. However, some patients do not respond or lose therapeutic benefit with first-line use of tumor necrosis factor (TNF) antagonists. We report a case of psoriasis vulgaris, that failed to respond to TNF antagonists, infliximab and adalimumab, completely disappeared after treatment with ustekinumab, a therapeutic agent for biologically blocking p40 protein of interleukin (IL) 12 and 23. This report highlights anti-TNF agents only inhibited the TNF-α/inducible nitric oxide synthase (iNOS)-producing dendritic cells (TIP-DCs), but the plasmacytoid-DC-derived psoriatic response was re-initiated. On the other hand, ustekinumab may inhibit both the TIP-DCs and the plasmacytoid-DC-derived inflammatory response

Authors and Affiliations

Chiharu Tateishi,, Kulsupa Nimmannitya, Hisayoshi Imanishi, Daisuke Tsuruta

Keywords

Related Articles

 Badania nad skórnymi manifestacjami cukrzycy

 Skórne manifestacje cukrzycy są zróżnicowane. Przeprowadziliśmy badania pięćdziesięciu pacjentów, chorych na cukrzcę z odziału dermatologii i medycyny. Najczęstszą skórną cechą cukrzycy były piodrmie - 40% pacjentó...

Hereditary benign intraepithelial dyskeratosis: Is this the first African case?

Inherited benign intraepithelial dyskeratosis (IBID) is a rare genodermatosis, affecting both the oral and conjunctival mucosa. We report a new case of a 10-year-old girl with clinico-histological manifestations of IBID...

 Study of fractional ablative laser in surgical and post traumatic scar

 Introduction: Ablative, fractional lasers generate microscopic columns of coagulated tissue through the epidermis and dermis to evoke a wound healing response. In this study, we examined the efficacy and safety of...

 Łojotokowe zapalenie skóry i homeopatia

Wprowadzenie: Łojotokowe zapalenie (ŁZS) skóry jest częstym, zazwyczaj łagodną dolegliwością skórną, występującą u obu płci. Zarówno niemowlęta, jak i dorośli mogą być dotknięci tym schorzeniem. ŁZS może powodować dyskom...

Download PDF file
  • EP ID EP132610
  • DOI 10.7241/ourd.20153.79
  • Views 100
  • Downloads 0

How To Cite

Chiharu Tateishi, , Kulsupa Nimmannitya, Hisayoshi Imanishi, Daisuke Tsuruta (2015). Ustekinumab successfully treated a patient with severe psoriasis vulgaris with primary failure to infliximab and secondary failure to adalimumab. Nasza Dermatologia Online, 6(2), 296-298. https://europub.co.uk/articles/-A-132610